Skip to main content

Table 1 Study criteria for Metabolic Syndrome (MetS) diagnosis

From: Metabolic syndrome diagnosis and widespread high grade prostatic intraepithelial neoplasia significantly increase prostate cancer risk: results from a multicenter biopsy study

Diagnosis of MetS requires:

Insulin resistance, identified by 1 of the following:

 Type 2 diabetes, Impaired fasting glucose, Impaired glucose tolerance,

 or for those with normal fasting glucose levels (<110 mg/dL), glucose uptake below the lowest quartile for background population under investigation under hyperinsulinemic, euglycemic conditions

Plus any 2 of the following:

 Antihypertensive medication and/or high blood pressure (≥140 mm Hg systolic or ≥90 mm Hg diastolic)

 Plasma triglycerides ≥150 mg/dL (≥1.7 mmol/L)

 HDL cholesterol <35 mg/dL (<0.9 mmol/L) in men or <39 mg/dL (1.0 mmol/L) in women

 BMI >30 kg/m2 and/or waist:hip ratio >0.9 in men, >0.85 in women

 Urinary albumin excretion rate ≥20 μg/min or albumin: creatinine ratio ≥30 mg/g

  1. Adapted from Grundy SM et al. [7]